Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Accumulated Depreciation (2023 - 2025)

Upstream Bio has reported Accumulated Depreciation over the past 3 years, most recently at $344000.0 for Q4 2025.

  • Quarterly results put Accumulated Depreciation at $344000.0 for Q4 2025, up 120.51% from a year ago — trailing twelve months through Dec 2025 was $344000.0 (up 120.51% YoY), and the annual figure for FY2025 was $344000.0, up 120.51%.
  • Accumulated Depreciation for Q4 2025 was $344000.0 at Upstream Bio, up from $287000.0 in the prior quarter.
  • Over the last five years, Accumulated Depreciation for UPB hit a ceiling of $344000.0 in Q4 2025 and a floor of $67000.0 in Q4 2023.
  • Median Accumulated Depreciation over the past 3 years was $199000.0 (2025), compared with a mean of $200142.9.
  • Peak annual rise in Accumulated Depreciation hit 168.22% in 2025, while the deepest fall reached 120.51% in 2025.
  • Upstream Bio's Accumulated Depreciation stood at $67000.0 in 2023, then soared by 132.84% to $156000.0 in 2024, then soared by 120.51% to $344000.0 in 2025.
  • The last three reported values for Accumulated Depreciation were $344000.0 (Q4 2025), $287000.0 (Q3 2025), and $241000.0 (Q2 2025) per Business Quant data.